National Health Investors (NYSE:NHI) Price Target Raised to $80.00 at Wells Fargo & Company

Key Points

• Wells Fargo & Company has raised the price target for National Health Investors (NHI) from $76.00 to $80.00, indicating a potential upside of 3.43% from the current price.
• Truist Financial also increased its price objective for NHI, now set at $81.00, with a "buy" rating, while overall, the stock holds an average rating of "Buy" with a consensus price target of $84.20.
• National Health Investors recently reported $1.22 earnings per share for the quarter, exceeding estimates and marking a 6.7% increase in revenue compared to the same quarter last year.

National Health Investors (NYSE:NHI - Get Free Report) had its price target increased by analysts at Wells Fargo & Company from $76.00 to $80.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an "equal weight" rating on the real estate investment trust's stock. Wells Fargo & Company's price target points to a potential upside of 2.14% from the company's current price.

Several other equities analysts have also recently issued reports on NHI. Wedbush upgraded shares of National Health Investors to a "strong-buy" rating in a research note on Wednesday, July 2nd. KeyCorp upgraded shares of National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 price objective on the stock in a research note on Thursday, July 10th. Finally, Truist Financial increased their price objective on shares of National Health Investors from $77.00 to $81.00 and gave the stock a "buy" rating in a research note on Friday, August 15th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Buy" and an average price target of $84.20.

National Health Investors Stock Up 0.9%

NHI stock traded up $0.68 during trading on Wednesday, hitting $78.33. 193,835 shares of the stock traded hands, compared to its average volume of 219,331. National Health Investors has a 1 year low of $65.13 and a 1 year high of $86.13. The firm's 50 day moving average is $72.74 and its two-hundred day moving average is $72.94. The stock has a market cap of $3.72 billion, a price-to-earnings ratio of 25.02, a price-to-earnings-growth ratio of 3.36 and a beta of 0.76. The company has a debt-to-equity ratio of 0.75, a current ratio of 10.91 and a quick ratio of 10.91.

National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The real estate investment trust reported $1.22 EPS for the quarter, beating the consensus estimate of $1.16 by $0.06. The company had revenue of $70.27 million for the quarter, compared to the consensus estimate of $86.46 million. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. National Health Investors's revenue for the quarter was up 6.7% on a year-over-year basis. During the same period in the prior year, the firm posted $1.18 EPS. On average, sell-side analysts anticipate that National Health Investors will post 4.41 EPS for the current year.

Institutional Investors Weigh In On National Health Investors

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Thrivent Financial for Lutherans bought a new stake in National Health Investors during the 2nd quarter worth approximately $975,000. CANADA LIFE ASSURANCE Co raised its stake in National Health Investors by 11.9% during the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 83,636 shares of the real estate investment trust's stock worth $5,870,000 after acquiring an additional 8,887 shares during the period. Tower Research Capital LLC TRC raised its stake in National Health Investors by 144.6% during the 2nd quarter. Tower Research Capital LLC TRC now owns 5,329 shares of the real estate investment trust's stock worth $374,000 after acquiring an additional 3,150 shares during the period. Sophron Capital Management L.P. bought a new stake in National Health Investors during the 2nd quarter worth approximately $1,009,000. Finally, Engineers Gate Manager LP raised its stake in National Health Investors by 18.7% during the 2nd quarter. Engineers Gate Manager LP now owns 39,022 shares of the real estate investment trust's stock worth $2,736,000 after acquiring an additional 6,140 shares during the period. Institutional investors own 62.51% of the company's stock.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.